Latest filing published 26 Jan 2021 for Prevail Therapeutics Inc..
Insider track record
Abeliovich ASA: trading record in brief
This profile gathers the share dealings of Abeliovich ASA in Prevail Therapeutics Inc. The record holds 4 filings, for trades running from 30 December 2020 to 22 January 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 26 January 2021 came the latest disclosure, a transaction in Prevail Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Abeliovich ASA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,385,756 sharesCommon StockSEC:0001209191-21-005459:0
- 5,256 shares@ US$0.180.0% of flowCommon StockSEC:0001209191-20-065696:0
- 120,537 shares@ US$10.2637.6% of flowCommon StockSEC:0001209191-20-065696:1
- 89,037 shares@ US$23.0262.4% of flowCommon StockSEC:0001209191-20-065696:2
4 of 4 declarations
